GW&K Investment Management’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-21,411
Closed -$1.21M 298
2018
Q2
$1.21M Sell
21,411
-799
-4% -$40.5K 0.02% 225
2018
Q1
$939K Buy
22,210
+399
+2% +$17.1K 0.02% 228
2017
Q4
$1.17M Buy
21,811
+6,025
+38% +$318K 0.02% 220
2017
Q3
$704K Sell
15,786
-260
-2% -$11.8K 0.01% 221
2017
Q2
$780K Sell
16,046
-372
-2% -$21.9K 0.01% 215
2017
Q1
$1.19M Buy
16,418
+118
+0.7% +$7.8K 0.02% 208
2016
Q4
$932K Sell
16,300
-2,934
-15% -$269K 0.02% 218
2016
Q3
$2.46M Sell
19,234
-1,198
-6% -$153K 0.05% 201
2016
Q2
$2.55M Buy
20,432
+2,228
+12% +$256K 0.05% 202
2016
Q1
$1.52M Buy
18,204
+8,367
+85% +$690K 0.03% 206
2015
Q4
$974K Sell
9,837
-153
-2% -$16.4K 0.02% 214
2015
Q3
$1.23M Buy
9,990
+270
+3% +$36.7K 0.03% 199
2015
Q2
$1.49M Sell
9,720
-114
-1% -$18.8K 0.03% 199
2015
Q1
$1.68M Buy
+9,834
New +$1.49M 0.04% 195

Other funds holding ELGX

GW&K Investment Management's ELGX Position: Q3 2018 in Review

GW&K Investment Management sold out of Endologix Inc (ELGX) in Q3 2018, closing a stake of 21,411 shares — an estimated $1.21M sold.

GW&K Investment Management first reported a position in ELGX in Q1 2015 and held it in 14 quarters. The position peaked at $2.55M in Q2 2016. 100 funds tracked by Wall St. Rank hold ELGX as of Q3 2018.

  • GW&K Investment Management reported no remaining Endologix Inc position as of Q3 2018 after selling out during the quarter.
  • GW&K Investment Management sold 21,411 Endologix Inc shares in Q3 2018, an estimated $1.21M.
  • GW&K Investment Management first reported a position in Endologix Inc in Q1 2015 and held it in 14 quarters.
  • GW&K Investment Management's Endologix Inc position peaked at $2.55M in Q2 2016.
  • 100 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2018.

Based on GW&K Investment Management's 13F filing for Q3 2018, filed 6 Nov 2018.